A pilot study of emollient therapy for the primary prevention of atopic dermatitis

Eric Simpson, Trista M. Berry, Peter A. Brown, Jon Hanifin

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Background: Prevention strategies in atopic dermatitis (AD) using allergen avoidance have not been consistently effective. New research reveals the importance of the skin barrier in the development of AD and possibly food allergy and asthma. Correcting skin barrier defects from birth may prevent AD onset or moderate disease severity. Objective: We sought to determine the feasibility of skin barrier protection as a novel AD prevention strategy. Methods: We enrolled 22 neonates at high risk for developing AD in a feasibility pilot study using emollient therapy from birth. Results: No intervention-related adverse events occurred in our cohort followed up for a mean time of 547 days. Of the 20 subjects who remained in the study, 3 (15.0%) developed AD, suggesting a protective effect when compared with historical controls. Skin barrier measurements remained within ranges seen in normal-appearing skin. Limitations: No conclusions regarding efficacy can be made without a control group. Conclusions: Skin barrier repair from birth represents a novel and feasible approach to AD prevention. Further studies are warranted to determine the efficacy of this approach.

Original languageEnglish (US)
Pages (from-to)587-593
Number of pages7
JournalJournal of the American Academy of Dermatology
Volume63
Issue number4
DOIs
StatePublished - Oct 2010

Fingerprint

Emollients
Atopic Dermatitis
Primary Prevention
Skin
Therapeutics
Parturition
Food Hypersensitivity
Feasibility Studies
Allergens
Asthma
Control Groups

Keywords

  • atopic dermatitis
  • emollient therapy
  • prevention therapy
  • skin barrier defects
  • skin barrier protection
  • stratum corneum

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

A pilot study of emollient therapy for the primary prevention of atopic dermatitis. / Simpson, Eric; Berry, Trista M.; Brown, Peter A.; Hanifin, Jon.

In: Journal of the American Academy of Dermatology, Vol. 63, No. 4, 10.2010, p. 587-593.

Research output: Contribution to journalArticle

@article{39c0b07c3a934b62a1c3f5e14aee589a,
title = "A pilot study of emollient therapy for the primary prevention of atopic dermatitis",
abstract = "Background: Prevention strategies in atopic dermatitis (AD) using allergen avoidance have not been consistently effective. New research reveals the importance of the skin barrier in the development of AD and possibly food allergy and asthma. Correcting skin barrier defects from birth may prevent AD onset or moderate disease severity. Objective: We sought to determine the feasibility of skin barrier protection as a novel AD prevention strategy. Methods: We enrolled 22 neonates at high risk for developing AD in a feasibility pilot study using emollient therapy from birth. Results: No intervention-related adverse events occurred in our cohort followed up for a mean time of 547 days. Of the 20 subjects who remained in the study, 3 (15.0{\%}) developed AD, suggesting a protective effect when compared with historical controls. Skin barrier measurements remained within ranges seen in normal-appearing skin. Limitations: No conclusions regarding efficacy can be made without a control group. Conclusions: Skin barrier repair from birth represents a novel and feasible approach to AD prevention. Further studies are warranted to determine the efficacy of this approach.",
keywords = "atopic dermatitis, emollient therapy, prevention therapy, skin barrier defects, skin barrier protection, stratum corneum",
author = "Eric Simpson and Berry, {Trista M.} and Brown, {Peter A.} and Jon Hanifin",
year = "2010",
month = "10",
doi = "10.1016/j.jaad.2009.11.011",
language = "English (US)",
volume = "63",
pages = "587--593",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - A pilot study of emollient therapy for the primary prevention of atopic dermatitis

AU - Simpson, Eric

AU - Berry, Trista M.

AU - Brown, Peter A.

AU - Hanifin, Jon

PY - 2010/10

Y1 - 2010/10

N2 - Background: Prevention strategies in atopic dermatitis (AD) using allergen avoidance have not been consistently effective. New research reveals the importance of the skin barrier in the development of AD and possibly food allergy and asthma. Correcting skin barrier defects from birth may prevent AD onset or moderate disease severity. Objective: We sought to determine the feasibility of skin barrier protection as a novel AD prevention strategy. Methods: We enrolled 22 neonates at high risk for developing AD in a feasibility pilot study using emollient therapy from birth. Results: No intervention-related adverse events occurred in our cohort followed up for a mean time of 547 days. Of the 20 subjects who remained in the study, 3 (15.0%) developed AD, suggesting a protective effect when compared with historical controls. Skin barrier measurements remained within ranges seen in normal-appearing skin. Limitations: No conclusions regarding efficacy can be made without a control group. Conclusions: Skin barrier repair from birth represents a novel and feasible approach to AD prevention. Further studies are warranted to determine the efficacy of this approach.

AB - Background: Prevention strategies in atopic dermatitis (AD) using allergen avoidance have not been consistently effective. New research reveals the importance of the skin barrier in the development of AD and possibly food allergy and asthma. Correcting skin barrier defects from birth may prevent AD onset or moderate disease severity. Objective: We sought to determine the feasibility of skin barrier protection as a novel AD prevention strategy. Methods: We enrolled 22 neonates at high risk for developing AD in a feasibility pilot study using emollient therapy from birth. Results: No intervention-related adverse events occurred in our cohort followed up for a mean time of 547 days. Of the 20 subjects who remained in the study, 3 (15.0%) developed AD, suggesting a protective effect when compared with historical controls. Skin barrier measurements remained within ranges seen in normal-appearing skin. Limitations: No conclusions regarding efficacy can be made without a control group. Conclusions: Skin barrier repair from birth represents a novel and feasible approach to AD prevention. Further studies are warranted to determine the efficacy of this approach.

KW - atopic dermatitis

KW - emollient therapy

KW - prevention therapy

KW - skin barrier defects

KW - skin barrier protection

KW - stratum corneum

UR - http://www.scopus.com/inward/record.url?scp=77956766210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956766210&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2009.11.011

DO - 10.1016/j.jaad.2009.11.011

M3 - Article

C2 - 20692725

AN - SCOPUS:77956766210

VL - 63

SP - 587

EP - 593

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -